TAK-085: Clinical Trials

2 trials of TAK-085, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow TAK-085: new trials by email Literature Review of TAK-085 trials Research Report on TAK-085

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
TAK-085, Not treated with omega-3-acid ethyl esters - Hyperlipidemia
Phase 4CompletedTakeda532016-12-272019-02-11
Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
TAK-085 - Hyperlipidemia
Phase 4CompletedTakeda372016-08-042019-05-06

Conditions studied

Hyperlipidemias (2)

Sponsors

Takeda (2)

Countries

Japan (2)

Results publications

PMID 32200533